Skip to main content
. 2017 Aug 23;8(14):2765–2773. doi: 10.7150/jca.19515

Figure 1.

Figure 1

Overall survival for the study cohort comprising 8564 patients with resectable pancreatic ductal adenocarcinoma. (A) Overall survival of patients with node-negative disease stratified by the 7th AJCC T classification system. (B) Overall survival of patients with node-negative disease stratified by the 8th AJCC T classification system. (C) Overall survival of patients with 7th T3N0 disease stratified by SEER region.